(Q46732643)

24 December 2017

title

Warfarin pharmacogenomics: a big step forward for individualized medicine: enlightened dosing of warfarin (English)

1 reference

24 December 2017

1 reference

1 reference

2

1 reference

24 December 2017

author name string

Darlene J Elias

series ordinal

1

1 reference

24 December 2017

publication date

27 February 2008

1 reference

24 December 2017

European Journal of Human Genetics

published in

1 reference

24 December 2017

volume

16

1 reference

24 December 2017

issue

5

1 reference

24 December 2017

page(s)

532-534

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.ejhg.5201945

exact match

0 references

cites work

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201945

7 January 2021

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201945

7 January 2021

Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201945

7 January 2021

Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201945

7 January 2021

Association of warfarin dose with genes involved in its action and metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201945

7 January 2021

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201945

7 January 2021

Genetic-based dosing in orthopedic patients beginning warfarin therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201945

7 January 2021

Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201945

7 January 2021

Identifiers

DOI

10.1038/SJ.EJHG.5201945

1 reference

24 December 2017

1 reference

24 December 2017